PRKAA2 and metabolic dysfunction-associated steatotic liver disease: AMP-activated protein kinase (AMPK) is a master cellular energy sensor that has received much attention as a promising therapeutic target for obesity-associated metabolic disorders, including NAFLD/NASH8–11.